← Leaderboards
Pierre P Massion
Vanderbilt University
$18,568,000
Attributed
$19,994,875
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$22,179,875 · 9
VA$0 · 2
By mechanism
U01$12,056,991 · 3
R01$5,268,890 · 2
P50$4,046,373 · 2
P30$807,621 · 2
I01$0 · 2
Top collaborators
- Charles A. Powell5 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- David O. Francis$3,456,343
- Lynn M Matrisian$19,522,211
- Victoria Youngblood$50,922
- Daniel A Barocas$3,581,756
Others in their field
Top investigators on “Malignant Neoplasm Of Lung”
- David Heimbrook · Leidos Biomedical Research, Inc.$349,639,893
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,674,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,410,512
- Norman Wolmark · Nsabp Foundation, Inc.$54,610,124
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
Research focus
Malignant Neoplasm Of LungMolecularMalignant NeoplasmsTumorBiological MarkersBiologicalBaseCohortTumor ProgressionDiagnosticProgramsFundingLeadTissuesEarly DiagnosisProteomicsLungMolecular ProfilingInstitutionResponseGenomicsPhenotypePublic Health RelevanceCessation Of Life
Grant awards (65)
Cancer Health Outcomes and Control Research Program$124,453
P30 · FY2021 · CA · contact PI
Cancer Health Outcomes and Control Research Program$124,453
P30 · FY2020 · CA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$910,582
U01 · FY2019 · CA · contact PI
Non-invasive evaluation of indeterminate pulmonary nodules$376,081
U01 · FY2019 · CA · contact PI
Phenotypic heterogeneity in small cell lung cancer.$0
I01 · FY2019 · VA · contact PI
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma$756,124
U01 · FY2018 · CA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$711,290
U01 · FY2018 · CA · contact PI
Non-invasive evaluation of indeterminate pulmonary nodules$387,713
U01 · FY2018 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$116,153
P30 · FY2018 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$9,999
P30 · FY2018 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$7,996
P30 · FY2018 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$7,968
P30 · FY2018 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$4,817
P30 · FY2018 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$4,734
P30 · FY2018 · CA · contact PI
Phenotypic heterogeneity in small cell lung cancer.$0
I01 · FY2018 · VA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$970,519
U01 · FY2017 · CA · contact PI
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma$727,581
U01 · FY2017 · CA · contact PI
Lung Adenocarcinoma Invasion Genomics$566,724
R01 · FY2017 · CA
Non-invasive evaluation of indeterminate pulmonary nodules$387,713
U01 · FY2017 · CA · contact PI
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma$316,000
U01 · FY2017 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$116,153
P30 · FY2017 · CA · contact PI
Phenotypic heterogeneity in small cell lung cancer.$0
I01 · FY2017 · VA · contact PI
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma$802,247
U01 · FY2016 · CA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$715,735
U01 · FY2016 · CA · contact PI
Lung Adenocarcinoma Invasion Genomics$566,724
R01 · FY2016 · CA
Non-invasive evaluation of indeterminate pulmonary nodules$387,713
U01 · FY2016 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$112,857
P30 · FY2016 · CA · contact PI
Phenotypic heterogeneity in small cell lung cancer.$0
I01 · FY2016 · VA · contact PI
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma$720,937
U01 · FY2015 · CA · contact PI
Lung Adenocarcinoma Invasion Genomics$566,724
R01 · FY2015 · CA
Non-invasive evaluation of indeterminate pulmonary nodules$303,826
U01 · FY2015 · CA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$199,469
U01 · FY2015 · CA · contact PI
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma$120,560
U01 · FY2015 · CA · contact PI
Non-invasive evaluation of indeterminate pulmonary nodules$113,114
U01 · FY2015 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$112,857
P30 · FY2015 · CA · contact PI
Translational Research and Interventional Oncology Research Program (TR) (Project-006)$65,181
P30 · FY2015 · CA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$598,467
U01 · FY2014 · CA · contact PI
Lung Adenocarcinoma Invasion Genomics$549,723
R01 · FY2014 · CA
Molecular Approaches to Early Detection of Lung Cancer$198,513
R01 · FY2014 · CA · contact PI
Lung Adenocarcinoma Invasion Genomics$603,855
R01 · FY2013 · CA
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$597,547
U01 · FY2013 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$240,555
R01 · FY2013 · CA · contact PI
Molecular Biomarkers of Small Cell Lung Cancer Behaviour$0
I01 · FY2013 · VA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$654,948
U01 · FY2012 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$262,459
R01 · FY2012 · CA · contact PI
Molecular Biomarkers of Small Cell Lung Cancer Behaviour$0
I01 · FY2012 · VA · contact PI
SPORE in Lung Cancer$2,185,000
P50 · FY2011 · CA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$666,254
U01 · FY2011 · CA · contact PI
MOLECULAR SIGNATURES OF NSCLC$361,369
P50 · FY2011 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$275,407
R01 · FY2011 · CA · contact PI
Molecular Biomarkers of Small Cell Lung Cancer Behaviour$0
I01 · FY2011 · VA · contact PI
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer$632,571
U01 · FY2010 · CA · contact PI
MOLECULAR SIGNATURES OF NSCLC$379,941
P50 · FY2010 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$216,242
R01 · FY2010 · CA · contact PI
MOLECULAR SIGNATURES OF NSCLC$379,496
P50 · FY2009 · CA · contact PI
Molecular Biomarkers of Small Cell Lung Cancer Behaviour$0
I01 · FY2009 · VA · contact PI
MOLECULAR SIGNATURES OF NSCLC$379,024
P50 · FY2008 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$232,876
R01 · FY2008 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$50,038
R01 · FY2008 · CA · contact PI
Molecular Signatures of Non-Small Cell Lung$361,543
P50 · FY2007 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$229,714
R01 · FY2007 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$134,216
R01 · FY2007 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$235,544
R01 · FY2006 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$99,943
R01 · FY2006 · CA · contact PI
Molecular Approaches to Early Detection of Lung Cancer$239,633
R01 · FY2005 · CA